Literature DB >> 2471549

Binding of a neuropeptide, substance P, to neutral and negatively charged lipids.

A Seelig1, P M Macdonald.   

Abstract

The binding of substance P (SP), a positively charged neurotransmitter peptide, to neutral and to negatively charged phospholipids has been investigated by means of a monolayer technique. Monolayers formed at room temperature from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), or mixtures of the two, were maintained throughout the course of a binding experiment at a constant surface pressure while the monolayer surface area was monitored. Injection of SP into the aqueous subphase (154 mM NaCl, 10 mM Tris adjusted to pH 7.4) led to an expansion of the monolayer surface area that was attributed to a spontaneous insertion of SP between the lipid molecules. A quantitative evaluation of the area increase at constant pressure yielded SP insertion isotherms that showed that levels of SP insertion increased directly with the monolayer POPG content and decreased to negligible levels at surface pressures above 35 +/- 1 mN/m. If electrostatic effects were ignored, these data showed biphasic behavior in Scatchard plots. The apparent binding constants ranged, at 20 mN/m, from (3.2 +/- 0.3) X 10(4) M-1 for 100% POPG monolayers to (2.0 +/- 0.05) X 10(3) M-1 for 25% POPG/75% POPC monolayers. At 32 mN/m, a monolayer surface pressure that mimics bilayer conditions, the apparent binding constant for a 100% POPG monolayer was measured to be (1.1 +/- 0.05) X 10(3) M-1. However, for a monolayer containing only 25% charged lipids, corresponding to a natural membrane composition, K app at 32 mN/m was estimated to be at most 41 M-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471549     DOI: 10.1021/bi00432a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Solution structure of the tachykinin peptide eledoisin.

Authors:  R Christy Rani Grace; Indu R Chandrashekar; Sudha M Cowsik
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

2.  Molecular dynamics study of substance P peptides in a biphasic membrane mimic.

Authors:  T Wymore; T C Wong
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

3.  Surface charging by large multivalent molecules. Extending the standard Gouy-Chapman treatment.

Authors:  S Stankowski
Journal:  Biophys J       Date:  1991-08       Impact factor: 4.033

4.  The conformation of substance P in lipid environments.

Authors:  D A Keire; T G Fletcher
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

5.  Membrane-Induced Structure of Scyliorhinin I: A Dual NK1/NK2 Agonist.

Authors:  Anjali Dike; Sudha M Cowsik
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

6.  Membrane insertion and lateral diffusion of fluorescence-labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers.

Authors:  S Frey; L K Tamm
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

7.  Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer.

Authors:  M R Wenk; T Alt; A Seelig; J Seelig
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

8.  Molecular dynamics study of substance P peptides partitioned in a sodium dodecylsulfate micelle.

Authors:  T Wymore; T C Wong
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

9.  1H nuclear magnetic resonance determination of the membrane-bound conformation of senktide, a highly selective neurokinin B agonist.

Authors:  B Bersch; P Koehl; Y Nakatani; G Ourisson; A Milon
Journal:  J Biomol NMR       Date:  1993-07       Impact factor: 2.835

10.  Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes.

Authors:  Hans Binder; Göran Lindblom
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.